Drug: DOXORUBICIN HCL Injury: Disease progression Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 118951622 | DOXORUBICIN HCL | Disease progression | PFIZER | 0.00 | 0 | 20160801 | US | |
| 123684964 | DOXORUBICIN HCL | Disease progression | PFIZER | 43.00 YR | M | 0 | 20160725 | US |
| 123712304 | DOXORUBICIN HCL | Disease progression | PFIZER | 43.00 YR | M | 0 | 20160726 | US |
| 126072162 | DOXORUBICIN HCL | Disease progression | PFIZER | 0.00 | M | 0 | 20160930 | US |
| 126898923 | DOXORUBICIN HCL | Disease progression | PFIZER | 58.00 YR | F | 0 | 20160926 | US |
| 127064181 | DOXORUBICIN HCL | Disease progression | PFIZER | 47.00 YR | F | 63 KG | 20160901 | US |
| 127103121 | DOXORUBICIN HCL | Disease progression | PFIZER | 59.00 YR | M | 0 | 20160902 | US |
Total Records: 7 Number of Pages: 1